Club general manager Don Sweeney said the reason for Rask’s decision was the fact that his wife had recently given birth, and she had to take care of two other children. Rask was against finishing the playoffs from the start.David Pastrňák did not intervene in the match again. The Czech striker missed the second match of the series, which the Bruins lost, due to health reasons.The series between Boston and Carolina is 1: 1 in Toronto. The Bruins won the opening match 4: 3 in the second overtime, the Hurricanes tied it after a 3: 2 victory.Rask, the holder of Vezin’s trophy for the best goalkeeper in the NHL in 2014 and a finalist in this year’s poll, complained after the loss that the playoffs without spectators lack the usual atmosphere. “It’s not like a hockey playoff. There are no fans, it’s more like an exhibition, “he said.
- Rinri Therapeutics raises £10 million to advance stem cell therapy for hearing loss
Rinri Therapeutics raises £10 million to advance stem cell therapy for hearing loss University of Sheffield spinout company, Rinri Therapeutics, has raised investment to advance its therapy for hearing lossThe company is developing a novel stem cell therapy to restore hearing and reverse sensorineural hearing lossThere are currently no pharmacological treatments available for this type of hearing lossUniversity of Sheffield spinout company, Rinri Therapeutics, has raised a total of £10 million from investors and the UK Future Fund to advance its novel stem cell therapy to restore hearing loss.The biotechnology company is developing a novel stem cell therapy to restore hearing and will use the £10 million raised from existing investors, Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures and BioCity alongside the UK Government Future Fund, to support the development of its novel stem cell therapy to reverse sensorineural hearing loss (SNHL).Rinri’s underlying technology is based on innovative research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield. It seeks to reverse SNHL through the repair of the damaged cytoarchitecture in the inner ear.SNHL happens when there is damage to the hair cells in the cochlea and/or to the auditory nerve. There are currently no pharmacological treatments available for SNHL despite the increasing number of patients that suffer from this condition globally.Professor Marcelo Rivolta, said: “This investment is a validation of the journey we started several years ago. We are very happy and grateful for the continued support from our investors, now together with the UK Future Fund. We believe the technology we are developing can have a substantial impact on the lives of people affected by hearing loss, and these funds will help us pave the way to a first in man clinical trial.”Dr Simon Chandler, CEO of Rinri Therapeutics, commented: “We are very pleased to receive continuing support from existing investors alongside matched funding from the UK Future Fund. Our major investors share the vision we have for our technology to bring transformational changes to the lives of patients suffering from hearing loss, and the proceeds from this fund raising will allow us to advance our pioneering journey towards first in-man clinical trials and to ultimately realise the potential of stem cell therapy to reverse sensorineural hearing loss.”Frank Kalkbrenner, Global Head of the Boehringer Ingelheim Venture Fund, said: “We are delighted to continue our backing of Rinri and its pioneering approach to hearing loss, now with the added endorsement and support of the Future Fund. We believe Rinri’s’ technology is differentiated from other approaches to hearing loss restoration and has the potential to make a significant impact on treatment.”Additional information Rinri Therapeutics is a private biotechnology company developing advanced stem cell-based therapeutics to restore hearing. The company’s pioneering technology seeks to reverse sensorineural hearing loss (SNHL) through the repair of the damaged cytoarchitecture in the inner ear. SNHL is estimated to affect 64 million patients in the US and 34 million in Europe. There are currently no pharmacological treatment options for SNHL patients.Rinri, is backed by Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures, BioCity and the University of Sheffield. Rinri was founded in late-2018 and is headquartered in Sheffield, UK. /Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here. Why?Well, unlike many news organisations, we have no sponsors, no corporate or ideological interests. We don’t put up a paywall – we believe in free access to information of public interest. Media ownership in Australia is one of the most concentrated in the world (Learn more). Since the trend of consolidation is and has historically been upward, fewer and fewer individuals or organizations control increasing shares of the mass media in our country. According to independent assessment, about 98% of the media sector is held by three conglomerates. This tendency is not only totally unacceptable, but also to a degree frightening). Learn more hereWe endeavour to provide the community with real-time access to true unfiltered news firsthand from primary sources. It is a bumpy road with all sorties of difficulties. We can only achieve this goal together. Our website is open to any citizen journalists and organizations who want to contribute, publish high-quality insights or send media releases to improve public access to impartial information. You and we have the right to know, learn, read, hear what and how we deem appropriate.Your support is greatly appreciated. All donations are kept completely private and confidential.Thank you in advance!Tags:biotechnology, cell therapy, clinical trials, Europe, Government, Investment, Professor, Sheffield, stem cells, technology, therapeutics, treatment, UK, UK Government, university, University of Sheffield
- Government Extends US$1.7M PRIDE Jamaica Programme
RelatedGovernment Extends US$1.7M PRIDE Jamaica Programme Government Extends US$1.7M PRIDE Jamaica Programme CommerceApril 8, 2013 RelatedGovernment Extends US$1.7M PRIDE Jamaica Programme RelatedGovernment Extends US$1.7M PRIDE Jamaica Programme FacebookTwitterWhatsAppEmail The Government of Jamaica has signed a letter of intent with the United States Agency for International Development (USAID), for the extension of the PRIDE Jamaica Programme, which is expected to bring about continued improvement in the tax administration system. The Promote, Renew, Invigorate, Develop, and Energize (PRIDE) Jamaica project, which is being funded at a cost of US$1.7 million, is in its second phase, and is expected to continue until March 2015. Under the initiative, the USAID will provide technical assistance to the Tax Administration Jamaica (TAJ), and other stakeholders to simplify and broaden the tax base in Jamaica. This will be done by improving tax administration, streamlining processes to make it easier and simpler for taxpayers to comply, and harmonising tax policy and legislation. Speaking at the signing ceremony held at the Ministry of Finance and Planning in Kingston, on April 5, Financial Secretary at the Ministry, Devon Rowe, said the Government is pleased to continue its partnership with the USAID. He noted that the partnership is a demonstration of the Ministry of Finance’s commitment to tax reform and also in ensuring that the gains, which have been achieved so far, are consolidated. “It is important that some of the issues that are being covered under the programme relate to risk management and improved auditing in the TAJ. And given the limited resources that the departments have, it’s important for us to utilise those resources as strategically as possible,” he stated. Mr. Rowe further pointed out that the fact that the programme has produced so many benefits to date, including the implementation of new mechanisms at the TAJ, augurs well for the future. For her part, Mission Director, USAID, Denise Herbol, said the programme highlights the commitment of the Jamaican government to ensuring that the work that is being done by Pride Jamaica to support efforts at the TAJ and Customs can continue. “I am very gratified that there is a commitment to continuing this programme, because I believe in and I know (the Ministry of Finance) believes in it,” she stated. The project, which started in 2010, also aims to provide support to the Government in its efforts to enhance the business environment by improving regulatory efficiency and increasing domestic revenue mobilisation through tax and customs reform. Expected results include: the identification of tens of millions of dollars in additional domestic revenue per annum; improved tax and customs compliance; increased number of audit cases closed; strengthened institutional capacity at TAJ and the Jamaica Customs Department; leveraging of additional resources from donors for tax administration reform; and improved transparency in customs, trade, and revenue collection. Contact: Athaliah Reynolds-Baker Advertisements